Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Equity Ratio (2019 - 2025)

Burning Rock Biotech has reported Equity Ratio over the past 7 years, most recently at 0.65 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 0.55% year-over-year to 0.65; the TTM value through Dec 2025 reached 0.65, down 0.55%, while the annual FY2025 figure was 0.65, 0.55% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.65 at Burning Rock Biotech, down from 0.68 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.87 in Q1 2021 and troughed at 0.65 in Q4 2025.
  • A 5-year average of 0.74 and a median of 0.73 in 2022 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: dropped 11.68% in 2022 and later increased 3.26% in 2025.
  • Year by year, Equity Ratio stood at 0.81 in 2021, then decreased by 9.9% to 0.73 in 2022, then increased by 1.26% to 0.74 in 2023, then fell by 11.2% to 0.66 in 2024, then fell by 0.55% to 0.65 in 2025.
  • Business Quant data shows Equity Ratio for BNR at 0.65 in Q4 2025, 0.68 in Q3 2025, and 0.68 in Q2 2025.